Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Navigating The Complexities Of Ophthalmic Clinical Trials: A Guide For Sponsors And CROs
By embracing decentralized models, leveraging mobile technology, and fostering strategic partnerships, sponsors and CROs can streamline ophthalmic clinical trials.
Meeting Eye Exam Needs At The Point Of Need
Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.
Building A Gold Standard Trial Experience In Japan
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
Developing Community-Based And Trial-Naïve Sites: The Real ROI
Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

Making The Lives Of Patients And Research Sites Easier
5/14/2025

Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.
Tailored Solutions For A Global Phase III Neovascular AMD Study
3/17/2025

How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept
12/17/2025

Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.
How To Establish Effective, Scalable Drug Safety Ops Across Vendors
7/9/2024

Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.
Key Strategies For Clinical Development In Rare Cancers
2/11/2025

Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

Helping You Solve Your Toughest Challenges – From Clinical Strategy To Commercial Success

Your team is dedicated to developing and delivering treatments to patients in need. It’s a complex journey and having the right partner, with the right experience, by your side can make the difference. Our team has extensive expertise developing strategies and designing solutions to address questions at various points along your drug development path. Let us take that expertise and put it to work for you.
Dual Sourcing: Mitigating Risk In Your Supply Chain

Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
Why Fee-Free Trial Participant Payments Always Pay Off

Remove the administrative burden of clinical trials for patients while ensuring compliance and offering global accessibility.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
Getting Biotechs GlobalReady

Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.